BUSINESS
Why Scott Gottlieb, the new US FDA chief, could be good news for Indian drug makers
The US FDA appointment is closely watched by Indian pharmaceutical industry which supplies 40 percent of the generic medications consumed in the US. The generic or copycat drugs account for more than 8 in 10 prescriptions. India has 572 US FDA compliant plants -- the highest outside US.